In recent years, increasing research has revealed the pivotal role of PLOD2 in various cancer types, particularly in breast cancer, hepatocellular carcinoma, bladder cancer, sarcomas, and renal cell carcinoma (Du et al., 2017; Qi and Xu, 2018). This evidence concerns the gene PLOD2 and hepatocellular carcinoma.